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Objective—To assess maternal and perinatal outcomes as a function of second stage labor duration.
Methods—We assessed outcomes in nulliparous laboring women enrolled in a trial of fetal pulse
oximetry.
Results—Of 5,341 participants, 4,126 reached the second stage. As duration of the second stage
increased, spontaneous vaginal delivery rates declined, from 85% when the duration was under one
hour to 9% when it was 5 hours or more. Adverse maternal outcomes significantly associated with
the duration of the second stage included chorioamnionitis (overall rate 3.9%), 3rd or 4th degree
perineal laceration (8.7%), and uterine atony (3.9%). Odds ratios (ORs) for each additional hour of
the second stage ranged from 1.3 to 1.8. Among individual adverse neonatal outcomes, only
admission to a neonatal intensive care unit was significantly associated with second stage duration
(OR 1.4).
Conclusions—The second stage does not need to be terminated for duration alone.
Introduction
Recent studies suggest that while the duration of the second stage of labor is associated with
increased risks of certain adverse maternal outcomes, there is no relationship between the
duration of the second stage and adverse neonatal outcomes. However, most studies of this
issue are from single centers,1-7 and all are based on retrospectively collected data. We
therefore took advantage of data collected during a randomized clinical trial to assess whether
there is a relationship between the duration of the second stage of labor in nulliparous women
and adverse maternal or neonatal outcomes using prospectively collected, multi-center data.
Material and Methods
This is a secondary analysis of a clinical trial of fetal pulse oximetry conducted at the 14 clinical
centers of the National Institute of Child Health and Human Development Maternal Fetal
Medicine Units Network. Participants were nulliparas carrying a singleton vertex fetus who
labored spontaneously or were induced at or beyond 36 weeks' gestation.8 The present analysis
was confined to participants who reached the second stage of labor. Exclusion criteria for the
trial included maternal fever immediately prior to randomization, and serious medical
conditions such as diabetes mellitus. Pregnancy-associated hypertension was not an exclusion
criterion. Each participating center had Institutional Review Board approval for the study.
Maternal and neonatal data were collected by trained research nurses, who were present during
the labor to manage the fetal oximeter. Duration of the second stage was calculated as the
number of minutes from the first cervical examination revealing full dilatation until delivery.
Maternal morbidities are limited to diagnoses made after the start of the second stage, including
chorioamnionitis, which for study purposes required that the clinical diagnosis had been made,
the intrapartum temperature reached at least 38° C, and at least one of the following was present:
uterine tenderness, foul smelling vaginal discharge or amniotic fluid, or maternal or fetal
tachycardia. The study diagnosis of endometritis required a clinical diagnosis and a post-
partum temperature of at least 38° C. Other maternal morbidities were defined on the basis of
clinical diagnoses. Perineal laceration data were collected only for women who delivered
vaginally.
Brachial plexus injury was confirmed by central review of records, and was diagnosed only
when the injury was present at neonatal discharge. Other neonatal morbidities were defined on
the basis of clinical diagnoses. In the original trial, a composite outcome of serious neonatal
morbidity was defined a priori, and consisted of any of the following: a 5-minute Apgar score
below 4, an umbilical artery pH value under 7.0, seizures, intubation in the delivery room,
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stillbirth, neonatal death, or admission to a neonatal intensive care unit (NICU) for more than
48 hours.
The second stage of labor was analyzed both as a continuous and as a dichotomous variable:
less than three hours versus three hours or greater. The division at three hours was based on
the conventional threshold for defining a prolonged second stage of labor in a nullipara
receiving epidural analgesia.9 Associations between duration of the second stage and the
various maternal and neonatal outcomes were analyzed using logistic regression for the
continuous duration and chi-square or Fisher's exact tests for the dichotomous measure.
Logistic regression models for both the continuous and dichotomous measures were used to
adjust for mode of delivery (spontaneous, operative vaginal, and cesarean). Additional models
adjusting for maternal body mass index at delivery and duration of the first stage of labor were
analyzed when the outcomes were frequent enough to support valid logistic regressions.
Due to the infrequency of brachial plexus injury, sepsis, and low 5-minute Apgar score, exact
logistic regression was used for these outcomes. All reported P values are two-sided and a P
< 0.05 was considered significant. No adjustments were made for multiple comparisons. SAS
software (SAS Institute, Inc, Cary, NC) and LogXact (Cytel Software Corp., Cambridge, MA)
software were used for analysis.
Results
Of 5,341 parturients enrolled in the clinical trial from May 2002 to February 2005, 4,126 (77%)
reached the second stage of labor and these 4,126 women and their neonates constitute the
study cohort (Table 1). There was no observed effect of the original clinical trial exposure
groups (fetal pulse oximetry or not) on either the duration of the second stage or the maternal
and neonatal outcomes of interest (data not shown). Therefore, all patients were analyzed
independent of fetal pulse oximetry use. As duration of the second stage increased, spontaneous
vaginal delivery rates declined, from 85.2% of those delivering with less than one hour in the
second stage down to 8.7% of those who remained in the second stage for 5 or more hours
(Table 2).
In unadjusted analyses, several adverse maternal outcomes were significantly associated with
the duration of the second stage, including chorioamnionitis, endometritis, 3rd or 4th degree
perineal laceration, uterine atony, and blood transfusion (Table 2). After adjustment for mode
of delivery, the association with endometritis and blood transfusion was no longer significant
(Table 2). There were no stillbirths or neonatal deaths, and one case of neonatal hypoxic
ischemic encephalopathy (in this case the duration of the second stage was 2 hrs, 11 minutes).
Without adjustment for mode of delivery, admission to a neonatal intensive care unit and the
composite of serious morbidities were the only two neonatal morbidities significantly
associated with 2nd stage duration (Table 2). Admission to a neonatal intensive care unit for at
least 48 hours is alone responsible for 62% (n = 64) of the neonatal composite; when limited
to the remaining components, the composite of morbidities is no longer associated with 2nd
stage duration. After adjustment for mode of delivery, only brachial plexus injury present at
discharge was associated with second stage duration (Table 2). The individual cases of brachial
plexus injury are described in Table 3.
The second stage of labor lasted at least three hours in 360 women, or 9 percent of the cohort.
In these women, rates of spontaneous vaginal delivery were significantly lower, and rates of
operative vaginal and cesarean delivery higher than in women in whom the second stage lasted
under three hours. Even so, the majority (55%) of the 360 women with a second stage of at
least three hours delivered vaginally. Sixty-one percent (n = 89) of cesareans with a second
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stage under three hours were performed for dystocia, versus 93% (n = 149) when the second
stage was longer.
In unadjusted analyses, second stage duration of at least three hours was associated with
significantly higher rates of chorioamnionitis, endometritis, 3rd or 4th degree perineal
lacerations, uterine atony, and blood transfusion (Table 4). After adjustment for mode of
delivery, the association with endometritis and blood transfusion was no longer significant
(Table 4). Without adjustment for mode of delivery, admission to a neonatal intensive care unit
and the composite of serious morbidities were the only two neonatal morbidities significantly
associated with a second stage duration of at least 3 hours (Table 4). However, after adjustment
for mode of delivery, neonatal outcomes did not differ significantly between the patients with
second stage < 3 versus ≥ 3 hours. Outcomes stratified by mode of delivery and duration of
second stage (< 3 hours or ≥ 3 hours) are presented in Table 5. Additional regression analyses
were performed that included body mass index at delivery and duration of the first stage of
labor; however, the results were essentially identical (data not shown).
Discussion
These data, prospectively collected from 14 centers, reaffirm that with current labor
management practices, the duration of the second stage of labor is associated principally with
adverse maternal as opposed to adverse neonatal outcomes. Without adjustment for mode of
delivery, of the several individual adverse neonatal outcomes that we examined, only one,
admission to a neonatal intensive care unit, correlated with second stage duration, and it, per
se, is not strictly a true morbidity. Likewise, the composite outcome of serious neonatal
morbidity was significantly associated with second stage duration, but the neonatal intensive
care unit admission component comprised 62% of this composite outcome. After controlling
for mode of delivery, only one adverse neonatal outcome, brachial plexus injury present at
discharge, correlated with second stage duration, and the absolute risk of this outcome (3/1,000)
was low.
Cohen, in a study of 4,403 nulliparas, was the first to observe that while certain maternal
morbidities, specifically post-partum hemorrhage and fever, were increased when the second
stage of labor was prolonged, neither 5-minute Apgar scores nor perinatal mortality were
related to second stage duration.1 Saunders et al. came to a similar conclusion in their
retrospective review of a regional obstetric database.10 Among 25,069 term deliveries,
maternal infection and post-partum hemorrhage were related to the duration of the second
stage, but neonatal condition, as reflected by low Apgar scores or admission to a special care
nursery, was not. Presumably because relatively few women in their cohort had second stage
durations that exceeded three hours, they limited their conclusions to durations that did not
exceed this threshold.
Menticoglou and his colleagues extended the work of Cohen and Saunders et al when they
reported that among 6,041 nulliparas, the second stage exceeded three hours in 11% and five
hours in 3%.3 They found no relationship in their cohort between second-stage duration and
low 5-minute Apgar score, neonatal seizures, or NICU admission. Moreover, one in four
women who was still undelivered after four hours in the second stage achieved vaginal delivery
in the next hour.
Janni et al reported that the duration of the second stage exceeded four hours in 4% of 1,457
women, and that second stage duration bore no relationship to neonatal outcome.4 His group
did observe that the rate of third degree perineal lacerations increased as the second stage
lengthened. For example, when the second stage was under two hours, the rate of such tears
was 3%, whereas it was 11% when the second stage lasted from 3-4 hours. More recently,
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Myles and Santolaya and Cheng et al have reported similar maternal and neonatal outcomes
in relationship to second stage duration.6,7 Our study is thus consistent with previous findings.
The strengths of our data are that they were prospectively accrued, reflect practice patterns and
outcomes from 14 centers, and were collected by research nurses present during the second
stage of labor and delivery. Weaknesses of our data include the fact that second stage labor
management was not standardized, which limits somewhat the value of the causal implications
of the data. That is, the complications that we observed in association with second stage
duration may not per se be due to duration, or at least duration alone. Similarly, for several of
the complications, our study design does not allow us to say that the complications would have
been avoided if the second stage had been terminated sooner. Another potential weakness is
that even with a sample size of over 4,000, our statistical power to detect an increased risk of
several complications in association with the duration of the second stage was low. Finally,
since 95% of women in the study cohort received epidural analgesia, our findings shouldn't be
generalized to women who labor without such analgesia.
Although we did not collect information on shoulder dystocia, we did collect information on
the often associated and more meaningful outcome of brachial plexus injury. By logistic
regression analysis, each additional hour in the second stage significantly increased the risk of
this outcome by approximately 80%. We caution, however, that this risk estimate is modeled,
and based on only 11 cases, and thus the 95% confidence interval is wide and consistent with
a risk increase of as little as 10% or as great as 280%. Moreover, in only two of the eleven
cases did the duration of the second stage equal or exceed three hours, and in only four was
birth weight at least 4000 gm. Finally, we did not follow-up the neonates beyond discharge,
which is important, since as many as 90% of brachial plexus injuries resolve spontaneously
without sequelae.11 Thus the clinical implications of this association are unclear.
In infants who are delivered vaginally, the risk of brachial plexus injury is increased at higher
birth weights.11 However, for two reasons, one statistical and one conceptual, we did not adjust
for birth weight in our regression models. First, the infrequency of brachial plexus injury
rendered such adjustment statistically unreliable. Second, birth weight can only be estimated
prior to delivery, and incorporation of such estimates into clinical management strategies is
generally unrewarding,11 especially if, as in this study, the majority of brachial plexus injuries
occurred in babies with birth weights below 4000 gm.
Our data should aid in counseling and in the management of the second stage of labor. They
support that extending the duration of the second stage of labor will allow some women to
successfully achieve vaginal delivery, even those few women in whom the second stage has
lasted five hours. These vaginal deliveries, however, have a cost, including higher rates of
significant perineal trauma, infectious morbidity, and uterine atony. Some women and their
caregivers will find these tradeoffs in attempting to avoid cesarean delivery acceptable, and
some will not. The only associated downsides for the fetus to a longer second stage are a higher,
but still low rate of admission to a neonatal intensive care unit, and, when adjustment is made
for mode of delivery, an increased relative, but still low absolute risk of brachial plexus injury
Again, how these risks are perceived and acted upon is likely to vary substantially.
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Table 1
Maternal and Neonatal Characteristics and Outcomes
Maternal Characteristics






Body mass index (kg/m2)
 Pre-pregnancy 25.0 ± 5.8
 Delivery 31.0 ± 6.0
Ethnic group
 Hispanic or Latino 1,010 (24.5)
 Not Hispanic or Latino 3,116 (75.5)




Use of oxytocin 3,592 (87.1)
Use of epidural analgesia 3,916 (94.9)
Duration of 1st stage of labor 13.6 ± 7.1
Type of delivery
 Spontaneous 3,054 (74.0)
 Operative vaginal 765 (18.5)
 Cesarean 307 (7.4)
Chorioamnionitis* 151 (3.9)
3rd or 4th degree perineal laceration** 332 (8.7)
Endometritis 121 (2.9)
Uterine atony 160 (3.9)
Blood transfusion 36 (0.9)
Neonatal Characteristics and Outcomes
Birthweight (gm) 3335 ± 451
5-minute Apgar < 4 3 (0.1)
Umbilical artery pH < 7.0*** 16 (0.5)
Intubation in delivery room 20 (0.5)
Neonatal intensive care admission 181 (4.4)
Sepsis 6 (0.1)
Brachial plexus injury 11 (0.3)
Composite# 104 (2.5)
Data are presented as mean (± standard deviation) or number (percent)
*




Values available for 3,524 fetuses.
#
Any of the following: a 5-minute Apgar score below 4, an umbilical artery pH under 7.0, seizures, intubation in the delivery room, stillbirth, neonatal
death, or admission to a neonatal intensive care unit for more than 48 hours


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Rouse et al. Page 9
Table 3
Selected characteristics of pregnancies complicated by brachial plexus injury
Duration of the Second Stage (hrs) Birth weight (gm) Method of Delivery Station* at Forceps
0.2 3000 Forceps +2
0.4 3220 Spontaneous







3.8 3135 Forceps +2
4.9 4460 Spontaneous
*
On a scale of 0-5 cm
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Table 4
Second stage duration and outcomes categorized by duration < or ≥ 3 hours
< 3 Hours (n = 3766) ≥ 3 Hours (N = 360) P (unadjusted) P (adjustedˆ)
Delivery Mode
 Spontaneous 2967 (78.8) 87 (24.2) <0.01 --
 Operative Vaginal 653 (17.3) 112 (31.1)
 Cesarean 146 (3.9) 161 (44.7)
Maternal outcomes
Chorioamnionitis 110 (3.1) 41 (12.5) <0.01 <0.01
3rd or 4th degree perineal laceration* 271 (7.5) 61 (30.7) <0.01 <0.01
Endometritis 99 (2.6) 22 (6.1) <0.01 0.20
Uterine atony 132 (3.5) 28 (7.8) <0.01 <0.01
Blood transfusion 29 (0.8) 7 (1.9) 0.03 0.24
Neonatal Outcomes
5-minute Apgar < 4 3 (0.1) 0 (0.0) 1.00 0.90
Umbilical artery pH < 7.0 14 (0.4) 2 (0.7) 0.64 0.50
Intubation in delivery room 19 (0.5) 1 (0.3) 1.00 0.23
Neonatal intensive care 152 (4.0) 29 (8.1) <0.01 0.25
Sepsis 6 (0.2) 0 (0.0) 1.00 0.72
Brachial plexus injury 9 (0.2) 2 (0.6) 0.25 0.27
Composite# 88 (2.3) 16 (4.4) 0.01 0.69
Data are presented as number (percent), or mean +/- SD
ˆ




Any of the following: a 5-minute Apgar score below 4, an umbilical artery pH under 7.0, seizures, intubation in the delivery room, stillbirth, neonatal
death, or admission to a neonatal intensive care unit for more than 48 hours
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